MedTrace Logo

Swiss Longitudinal Cohort

NCT02282748 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-02-18

No results posted yet for this study

Summary

The planned research project is a prospective population-based cohort study, similar to the well-known Framingham study in the United States. So far, there is no similar research project in Switzerland.

It is planned to examine of three Swiss municipalities. Recruitment in a first Swiss municipality (Lostallo/Cama GR) started 2014 and ended in 2019. Overall, 496 participants were recruited in this municipality. The five-year follow-up in this municipality started in 2019. It is planned to start recruitment in a second Swiss municipality (Uznach SG) in 2020.

The examinations embrace a broad spectrum of measurements (for details the investigators refer to the published study protocol).

Conditions

  • Cardiovascular Risk Factors

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Hypertension Excellence Centre Lucerne

    lead OTHER

Principal Investigators

  • Paul Erne, MD · Hypertension Excellence Centre Lucerne

  • Andreas W Schoenenberger, MD · University Department of Geriatrics, University of Bern

  • Paolo Suter, MD · University of Zurich

  • Franco Muggli, MD · Swiss Society of Hypertension

  • Renate Schoenenberger, MD · Hypertension Excellence Centre Lucerne

  • Pierre-Alexandre Krayenbühl, MD · Linth Hospital

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2024-09-30
Completion
2034-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02282748 on ClinicalTrials.gov